Iraqi Journal of Embryos and Infertility Researches
Login
IJEIR
  • Home
  • Articles & Issues
    • Latest Issue
    • All Issues
  • Authors
    • Submit Manuscript
    • Guide for Authors
    • Authorship
    • Article Processing Charges (APC)
  • Reviewers
    • Guide for Reviewers
    • Become a Reviewer
  • Policies
    • Publication Ethics
    • Plagiarism
    • Allegations of Misconduct
    • Appeals and Complaints
    • Corrections and Withdrawals
    • Open Access
    • Copyright Policy
    • Archiving Policy
    • Privacy Policy
  • About
    • About Journal
    • Aims and Scope
    • Editorial Team
    • Journal Insights
    • Peer Review Process
    • Announcements
    • Contact

Search Results for follistatin-hormone

Article
Relationship between antiMüllerian ovarian hormone, activin-A, and follistatin hormones levels with pregnancy rate following intrauterine insemination

Saad S. Al-Dujaily, Nidhal Salim Alwan

Pages: 2-10

PDF Full Text
Abstract

Background: Recently the reproductive hormones, Anti-Mullerian hormone (AMH), activin A, and follistatin (FS) have been found to play an important role in folliculogenesis, oocyte maturation and corpus luteum function by changing the pattern of granulosa cell expression which in turn affects the success of fertilization potential. Objectives: To examine the relation of in vivo concentrations of AMH, activin A, and FS hormones on the ovaries status in the phases of menstrual cycle and to elucidate the relationship of these hormones with pregnancy rate following intrauterine insemination(IUI). Materials and methods: Seventy seven infertile couples were recruited from infertility clinic population at the High Institute for Infertility Diagnosis and Assisted Reproductive Technologies through the period from September 2011 to May 2012. Those infertile couples were divided to 3 groups according to the infertility cause (male factors causes, anovulatory causes and unexplained causes of infertility). Measurements of AMH, activin A, and FS hormones levels were done at cycle day (CD25-). Then measurements of activin A, and FS hormones levels were done only at preovulatory cycle(CD1214-) when the size of the Graffian follicle range between 1824-mm and at least one follicle was present and before hCG injection and at day 28 of the cycle (CD28). IUI was performed 3640- hours after hCG injection then measurement of the three hormones was performed after successful IUI. The result of successful pregnancy was recorded and statistical relation with AMH, activin A and FS hormones was assessed. Results: There was a positive significant correlation between endometrial thickness (ET) and pregnancy rate and the best ET to predict pregnancy is more than 7mm. There was no significant relation (P>0.05) between AMH level and pregnancy rate. A significant correlation was found between follistatin levels in preovulatory (CD 1214-) with a cutoff value 0.20ng/ml to predict pregnancy. There was a significant relation between activin-A level and pregnancy rate with a predictive cut off value 397.5 ng/ml on (CD 28) only. Conclusions: Activin-A can be regarded as a biomarker candidate for diagnosing very early pregnancy at luteal phase following IUI. Follistatin preovulatory (average CD13) has the most predictive value for pregnancy following IUI.

1 - 1 of 1 items

Search Parameters

Journal Logo
Iraqi Journal of Embryos and Infertility Researches (IJEIR)

High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University

  • Copyright Policy
  • Terms & Conditions
  • Privacy Policy
  • Accessibility
  • Cookie Settings
Licensing & Open Access

CC BY 4.0 Logo Licensed under CC-BY-4.0

This journal provides immediate open access to its content.

Editorial Manager Logo Elsevier Logo

Peer-review powered by Elsevier’s Editorial Manager®

Copyright © 2026 Al-Nahrain University, its licensors, and contributors. All rights reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.